Iron Deficiency Anemia and Celiac Disease

Deep Dive

From a Western clinical viewpoint, the relationship between celiac disease and iron deficiency anemia (IDA) is mechanistically direct and clinic... From a Western clinical viewpoint, the relationship between celiac disease and iron deficiency anemia (IDA) is mechanistically direct and clinically meaningful. Iron absorption occurs predominantly in the duodenum, and this is the segment most damaged in untreated celiac disease. Autoimmune-mediated villous atrophy and crypt hyperplasia reduce absorptive surface area and disrupt the expression and function of iron transporters. Superimposed mucosal inflammation induces cytokines such as interleukin‑6, which upregulate hepcidin—the master iron-regulatory peptide—further restricting dietary iron uptake and iron release from macrophages. Occult mucosal bleeding and coexisting conditions, including autoimmune gastritis or Helicobacter pylori infection, can add to iron loss or limit absorption. Clinically, anemia is present in a significant proportion of individuals at celiac diagnosis, and in some, isolated IDA is the only clue, with few or no gastrointestinal symptoms. For this reason, guidelines recommend celiac serology in the evaluation of otherwise unexplained or recurrent IDA. The standard diagnostic pathway includes iron studies (low ferritin confirms iron deficiency in the absence of inflammation), celiac serology (tTG‑IgA with total IgA; IgG-based tests for IgA deficiency), and confirmatory duodenal biopsies when indicated. Parallel evaluation for other sources of iron loss—particularly gynecologic bleeding and gastrointestinal bleeding—remains necessary. Treatment priorities are twofold: correct the anemia and remove the cause. A strict gluten-free diet (GFD) is the cornerstone therapy for celiac disease and leads to mucosal healing and restoration of iron absorption capacity. As the gut heals, most patients respond well to oral iron; some require intravenous iron early on if anemia is severe, symptomatic, or if oral iron is not tolerated or clearly ineffective. Hemoglobin typically rises within weeks, with normalization and ferritin repletion over months (often 6–12 months, sometimes longer). Monitoring includes CBC, ferritin, transferrin saturation, and celiac serology to assess dietary adherence. Nutritional counseling is critical to ensure adequate iron intake on a GFD, which may be less fortified. Addressing concurrent deficiencies (folate, vitamin B12) and coexisting contributors (H. pylori, menorrhagia) improves outcomes. The clinical implication is straightforward: test for celiac disease in unexplained IDA and, once diagnosed, treat both conditions in tandem to achieve durable recovery and prevent recurrence.